✦ LIBER ✦

Acute myeloid leukemia after iodine-131 treatment for thyroid disorders

✍ Scribed by L. Laurenti; P. Salutari; S. Sica; N. Piccirillo; G. Zini; M. Zollino; G. Leone

Publisher: Springer
Year: 1998
Tongue: English
Weight: 129 KB
Volume: 76
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s002770050400

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytogenetic damage after 131-iodine trea

Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer

✍ Sara Gutiérrez; Elisabet Carbonell; Pere Galofré; Amadeu Creus; Ricardo Marcos 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 140 KB

Therapy-related acute myeloid leukemia a

✍ Clarence C.K. Lam; Edmond S.K. Ma; Yok-Lam Kwong 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 2 views

Philadelphia-negative acute myeloid leuk

Philadelphia-negative acute myeloid leukemia with new chromosomal abnormalities developing after first-line imatinib treatment for chronic phase chronic myeloid leukemia

✍ Carmen Fava; Jorge Cortes 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 2 views

## Induction of integrin b 1 expression in bone marrow cells after chemotherapy correlates with the overexpression of lung resistance protein and poor outcome in patients with multiple myeloma To the Editor: Acquired drug resistance continues to be one of the major obstacles hindering the successf

Growth and endocrinological disorders up

Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood

✍ Birkebæk, N. H.; Fisker, S.; Clausen, N.; Tuovinen, V.; Sindet-Pedersen, S.; Chr 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

## Background: Our aim was to evaluate endocrinological status 10-21 years after treatment for childhood acute lymphoblastic leukemia (all) with chemotherapy (c) and cranial irradiation (c + i) or only c, and to correlate the endocrine data with growth parameters. ## Procedure: Of 30 patients (15

Fludarabine, cytarabine, and G-CSF (FLAG

Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantation

✍ F. Ferrara; L. Melillo; M. Montillo; F. Leoni; A. Pinto; G. Mele; S. Mirto 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 64 KB

Antifungal treatment by amphotericin B a

Antifungal treatment by amphotericin B and 5-fluorocytosine delays the recovery of normal hematopoietic cells after intensive cytostatic therapy for acute myeloid leukemia

✍ W. Hiddemann; M. E. Essink; W. Fegeler; M. Zühlsdorf; C. Sauerland; Th. Büchner 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 573 KB

Systemic fungal infections are recognized at increasing frequency during the course of intensive therapy for acute leukemias and require parenteral antifungal treatment mostly by amphotericin B (ampho B) alone or in combination with 5-Fluorocytosine (5-FC). Because of the potential myelosuppressive